Search Clinical Trials
589,279 trials
ID
Status
Phase
Title
Sponsor
NCT07648407
Therapeutic Induction of Dermal Remodeling in Veterans to Prevent Actinic Neoplasia Caused by Chronic Environmental Exposure to Ultraviolet RadiationVA Office of Research and DevelopmentNot Yet RecruitingNot Applicable
NCT07648407Not Yet Recruiting
Not Applicable
Therapeutic Induction of Dermal Remodeling in Veterans to Prevent Actinic Neopla...VA Office of Research and...
NCT07648615
Efficacy of a Tinnitus Implant for People With Severe Tinnitus Without Damaging the Acoustic Hearing.ENTIC research and training centre of the European Institute for ORLNot Yet RecruitingNot Applicable
NCT07648615Not Yet Recruiting
Not Applicable
Efficacy of a Tinnitus Implant for People With Severe Tinnitus Without Damaging...ENTIC research and traini...
NCT07648849
Arthroscopic Versus Open Management of Lateral Epicondylitis Elbow (Randomized Control Trial)Assiut UniversityNot Yet RecruitingNot Applicable
NCT07648849Not Yet Recruiting
Not Applicable
Arthroscopic Versus Open Management of Lateral Epicondylitis Elbow (Randomized C...Assiut University
NCT07647991
The IGBallon (R) - for Use in the Treatment of ObesityMedical University of ViennaCompletedNot Applicable
NCT07647991Completed
Not Applicable
The IGBallon (R) - for Use in the Treatment of ObesityMedical University of Vie...
NCT07648264
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesCSL BehringNot Yet RecruitingPhase 3
NCT07648264Not Yet Recruiting
Phase 3
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to...CSL Behring
NCT07648602
PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional StudyCorEvitasRecruiting
NCT07648602Recruiting
—
PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Stud...CorEvitas
NCT07646717
Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic CholangiocarcinomaTianjin Medical University Cancer Institute and HospitalActive Not RecruitingPhase 2
NCT07646717Active Not Recruiting
Phase 2
Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Adv...Tianjin Medical Universit...
NCT07647757
Neurolyser XR for the Treatment of SacroiliitisFederico II UniversityNot Yet RecruitingNot Applicable
NCT07647757Not Yet Recruiting
Not Applicable
Neurolyser XR for the Treatment of SacroiliitisFederico II University
NCT07648329
Association Between Circulating BDNF Levels and Atrial Cardiomyopathy in Patients Undergoing Ablation for Persistent Atrial FibrillationCentre Hospitalier Universitaire DijonNot Yet Recruiting
NCT07648329Not Yet Recruiting
—
Association Between Circulating BDNF Levels and Atrial Cardiomyopathy in Patient...Centre Hospitalier Univer...
NCT07646613
Study VFC202-201 is a Randomized, Double-blind, Placebo-controlled, Crossover, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of MigraineAspeya, Inc.RecruitingPhase 2
NCT07646613Recruiting
Phase 2
Study VFC202-201 is a Randomized, Double-blind, Placebo-controlled, Crossover, M...Aspeya, Inc.
NCT07647913
Rhythm Psychophysics With Parkinson's PatientsMcMaster UniversityNot Yet RecruitingNot Applicable
NCT07647913Not Yet Recruiting
Not Applicable
Rhythm Psychophysics With Parkinson's PatientsMcMaster University
NCT07648953
Microvideos for Improving HPV Vaccination Among Childhood Cancer SurvivorsHuntsman Cancer InstituteRecruitingNot Applicable
NCT07648953Recruiting
Not Applicable
Microvideos for Improving HPV Vaccination Among Childhood Cancer SurvivorsHuntsman Cancer Institute
NCT07647432
HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIVPfizerNot Yet RecruitingPhase 2
NCT07647432Not Yet Recruiting
Phase 2
HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed...Pfizer
NCT07647874
Assessment of Spirulina Gel Prepared By Different Extraction Methods as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B PeriodontitisMansoura UniversityCompletedEarly Phase 1
NCT07647874Completed
Early Phase 1
Assessment of Spirulina Gel Prepared By Different Extraction Methods as an Adjun...Mansoura University
NCT07647835
3 vs. 5 Days of Amoxicillin for Childhood Pneumonia: An RCTKhyber Teaching HospitalNot Yet RecruitingEarly Phase 1
NCT07647835Not Yet Recruiting
Early Phase 1
3 vs. 5 Days of Amoxicillin for Childhood Pneumonia: An RCTKhyber Teaching Hospital
NCT07648745
Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian CancerAstraZenecaCompletedPhase 2
NCT07648745Completed
Phase 2
Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian CancerAstraZeneca
NCT07646977
CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)Odense University HospitalNot Yet RecruitingNot Applicable
NCT07646977Not Yet Recruiting
Not Applicable
CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With...Odense University Hospita...
NCT07648485
Clinical Performance of CAD/CAM Hard Hybrid Ceramic Inlays Versus Resin Composite Inlays in Vital Molars With Extensive Occluso-Proximal Cavities: Two-Year Randomized Clinical TrialCairo UniversityNot Yet RecruitingNot Applicable
NCT07648485Not Yet Recruiting
Not Applicable
Clinical Performance of CAD/CAM Hard Hybrid Ceramic Inlays Versus Resin Composit...Cairo University
NCT07648173
Hybrid HIIT-FES Cycling Program on Individuals With Spinal Cord Injury to Improve HealthWilliam Carey UniversityRecruitingNot Applicable
NCT07648173Recruiting
Not Applicable
Hybrid HIIT-FES Cycling Program on Individuals With Spinal Cord Injury to Improv...William Carey University
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Phase 24 (20%)
Not Specified2 (10%)
Early Phase 12 (10%)
Phase 31 (5%)